FDA Defends Its Line Of Communication As Lifecore Revamps MDR Procedures
This article was originally published in The Gray Sheet
Executive Summary
Lifecore Biomedical had sufficient opportunity to obtain FDA guidance on medical device reporting (MDR) for theIntergel adhesion prevention solution, despite the firm's claims to the contrary, the agency maintains in a Dec. 1 letter